AKT1 and breast carcinoma: While initial findings demonstrated that silencing RICTOR dramatically diminished AKT activation in response to SESN2 induction in the MCF7 breast carcinoma cell line [32], the precise role of mTORC2 in Sestrin-mediated AKT regulation continues to be explored [33,34].